Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study

Stefan Walter1, Jessica R Marden, Laura D Kubzansky

  • 1*Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco ∥Department of Medicine, Division of General Medical Disciplines, Stanford University, Stanford, CA Departments of †Social and Behavioral Sciences §Nutrition, Harvard School of Public Health, Boston, MA ‡Department of Medicine, Division of General Internal Medicine, University of Washington, Seattle, WA.

Abstract

Insights

Type 2 diabetes (T2D) may not directly cause Alzheimer's disease (AD). However, impaired insulin sensitivity, a factor in T2D, appears to increase AD risk, suggesting a specific mechanism is involved.

Area of Science:

  • Genetics
  • Neuroscience
  • Metabolic Disorders

Background:

  • Previous Mendelian Randomization (MR) studies found no association between type 2 diabetes (T2D) and Alzheimer's disease (AD).
  • This study investigates potential underlying mechanisms linking T2D and AD using a refined MR approach.

Purpose of the Study:

  • To explore the surprising lack of association between T2D and AD reported in prior MR studies.
  • To investigate if specific T2D-related mechanisms, such as insulin sensitivity, impact AD risk.

Main Methods:

  • Employed inverse-variance weighted MR analysis using genetic data from large consortia (DIAGRAM, IGAP).
  • Examined associations between T2D and AD using 39 single nucleotide polymorphisms (SNPs).
  • Evaluated mechanism-specific genetic subscores (beta-cell function, insulin sensitivity, adiposity) and validated findings in the Health and Retirement Study.

Main Results:

  • The overall T2D polygenic score did not predict AD risk in the International Genomics of Alzheimer's Project (IGAP).
  • However, an insulin sensitivity polygenic score significantly predicted higher AD risk (OR=1.17, 95% CI: 1.02-1.34).
  • Replication in the Health and Retirement Study showed polygenic scores associated with T2D risk, but insulin sensitivity's link to cognitive phenotypes was not significant.

Conclusions:

  • Findings suggest insulin sensitivity, rather than T2D overall, may be a key factor influencing Alzheimer's disease risk.
  • This highlights the importance of investigating specific pathophysiological pathways in complex disease associations.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
109
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.8K
Genetic Lingo01:11

Genetic Lingo

Overview
117.6K